A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition
Clinical trial NCT04654468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04654468
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2022-02-10
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.